Recognizing Fenwick’s resounding impact over the last year, Law360 has named our life sciences team a Practice Group of the Year for 2023. The honor acknowledges Fenwick’s deep expertise and formidable track record successfully guiding the world’s leading biopharma, medical device, diagnostic, and healthcare companies through growth-catalyzing fundraising, pivotal collaborations, industry-shaping mergers, and their highest-stakes disputes.
Enhanced by our vast technical background, deep scientific understanding, and inherently collaborative nature, Fenwick’s ability to keep pace with our disruptive and transformative clients—especially when the law cannot—has long differentiated us. We’re thrilled to see the legal industry once again take notice.
Fenwick successes that caught Law360’s attention include:
Our life sciences group’s other accolades this year include:
Fenwick is a leading law firm, purpose-built to guide visionary tech and life sciences companies and their investors through every stage of growth, from startups securing their first round of funding to publicly traded global conglomerates. As one of Silicon Valley’s original legal practices, today we have over 500 lawyers, patent agents, engineers and scientists serving clients from seven offices strategically located in tech hubs across the United States and China. We are consistently ranked a Chambers first-tier firm for delivering deep experience and technical skill that helps innovators at the forefront of their industries shatter boundaries and redefine what’s possible. Visit www.fenwick.com to learn more.